Continental Advisors’s Exact Sciences EXAS Stock Holding History

Continental Advisors’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-18,000	Closed	-$121K	–	126
2016 Q1	$121K	Hold	18,000	–	–	0.03%	129
2015 Q4	$166K	Buy	+18,000	New	+$167K	0.04%	142

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Continental Advisors's EXAS Position: Q2 2016 in Review

Continental Advisors sold out of Exact Sciences (EXAS) in Q2 2016, closing a stake of 18,000 shares — an estimated $121K sold.

Continental Advisors first reported a position in EXAS in Q4 2015 and held it in 2 quarters. The position peaked at $166K in Q4 2015. 181 funds tracked by Wall St. Rank hold EXAS as of Q2 2016.

Continental Advisors reported no remaining Exact Sciences position as of Q2 2016 after selling out during the quarter.
Continental Advisors sold 18,000 Exact Sciences shares in Q2 2016, an estimated $121K.
Continental Advisors first reported a position in Exact Sciences in Q4 2015 and held it in 2 quarters.
Continental Advisors's Exact Sciences position peaked at $166K in Q4 2015.
181 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2016.

Based on Continental Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.